CD4 and infection: Additionally, in a Th2-skewed formalin-inactivated respiratory syncytial virus (FI-RSV) vaccination model in mice, acidic HMOs were shown to reduce RSV-specific Th2 cytokine-producing CD4+ T-Cells 4- and 6-days post-infection.